532 related articles for article (PubMed ID: 28607110)
1. The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis.
Biagioli M; Carino A; Cipriani S; Francisci D; Marchianò S; Scarpelli P; Sorcini D; Zampella A; Fiorucci S
J Immunol; 2017 Jul; 199(2):718-733. PubMed ID: 28607110
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
Renga B; Cipriani S; Carino A; Simonetti M; Zampella A; Fiorucci S
PLoS One; 2015; 10(11):e0141082. PubMed ID: 26539823
[TBL] [Abstract][Full Text] [Related]
3. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.
Carino A; Marchianò S; Biagioli M; Bucci M; Vellecco V; Brancaleone V; Fiorucci C; Zampella A; Monti MC; Distrutti E; Fiorucci S
FASEB J; 2019 Feb; 33(2):2809-2822. PubMed ID: 30303744
[TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype.
Högenauer K; Arista L; Schmiedeberg N; Werner G; Jaksche H; Bouhelal R; Nguyen DG; Bhat BG; Raad L; Rauld C; Carballido JM
J Med Chem; 2014 Dec; 57(24):10343-54. PubMed ID: 25411721
[TBL] [Abstract][Full Text] [Related]
5. Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice.
Carino A; Cipriani S; Marchianò S; Biagioli M; Scarpelli P; Zampella A; Monti MC; Fiorucci S
Sci Rep; 2017 Oct; 7(1):13689. PubMed ID: 29057935
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells.
Munakata S; Tashiro Y; Nishida C; Sato A; Komiyama H; Shimazu H; Dhahri D; Salama Y; Eiamboonsert S; Takeda K; Yagita H; Tsuda Y; Okada Y; Nakauchi H; Sakamoto K; Heissig B; Hattori K
Gastroenterology; 2015 Mar; 148(3):565-578.e4. PubMed ID: 25490065
[TBL] [Abstract][Full Text] [Related]
7. GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis.
Biagioli M; Carino A; Fiorucci C; Marchianò S; Di Giorgio C; Roselli R; Magro M; Distrutti E; Bereshchenko O; Scarpelli P; Zampella A; Fiorucci S
Cell Mol Gastroenterol Hepatol; 2019; 8(3):447-473. PubMed ID: 31226434
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of κ-carrageenan on oxazolone-induced inflammation in BALB/c mice.
Wu W; Wang F; Gao X; Niu T; Zhu X; Yan X; Chen H
BMC Gastroenterol; 2016 Mar; 16():41. PubMed ID: 27015810
[TBL] [Abstract][Full Text] [Related]
9. The bile acid receptor FXR is a modulator of intestinal innate immunity.
Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 induces an atypical M2-like macrophage subpopulation that regulates intestinal inflammation.
Nishikawa K; Seo N; Torii M; Ma N; Muraoka D; Tawara I; Masuya M; Tanaka K; Takei Y; Shiku H; Katayama N; Kato T
PLoS One; 2014; 9(9):e108494. PubMed ID: 25254662
[TBL] [Abstract][Full Text] [Related]
11. Disequilibrium of M1 and M2 macrophages correlates with the development of experimental inflammatory bowel diseases.
Zhu W; Yu J; Nie Y; Shi X; Liu Y; Li F; Zhang XL
Immunol Invest; 2014; 43(7):638-52. PubMed ID: 24921428
[TBL] [Abstract][Full Text] [Related]
12. GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation.
Biagioli M; Marchianò S; Roselli R; Di Giorgio C; Bellini R; Bordoni M; Distrutti E; Catalanotti B; Zampella A; Graziosi L; Donini A; Fiorucci S
Cells; 2022 Apr; 11(7):. PubMed ID: 35406751
[TBL] [Abstract][Full Text] [Related]
13. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis.
Marcon R; Bento AF; Dutra RC; Bicca MA; Leite DF; Calixto JB
J Immunol; 2013 Oct; 191(8):4288-98. PubMed ID: 24038091
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
[TBL] [Abstract][Full Text] [Related]
15. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11.
Waddell A; Ahrens R; Steinbrecher K; Donovan B; Rothenberg ME; Munitz A; Hogan SP
J Immunol; 2011 May; 186(10):5993-6003. PubMed ID: 21498668
[TBL] [Abstract][Full Text] [Related]
16. Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis.
Lu N; Wang L; Cao H; Liu L; Van Kaer L; Washington MK; Rosen MJ; Dubé PE; Wilson KT; Ren X; Hao X; Polk DB; Yan F
J Immunol; 2014 Feb; 192(3):1013-23. PubMed ID: 24391216
[TBL] [Abstract][Full Text] [Related]
17. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
18. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
[TBL] [Abstract][Full Text] [Related]
19. The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity.
Biagioli M; Carino A; Fiorucci C; Marchianò S; Di Giorgio C; Bordoni M; Roselli R; Baldoni M; Distrutti E; Zampella A; Fiorucci S
J Immunol; 2020 May; 204(9):2535-2551. PubMed ID: 32213564
[TBL] [Abstract][Full Text] [Related]
20. A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo.
Lewis ND; Patnaude LA; Pelletier J; Souza DJ; Lukas SM; King FJ; Hill JD; Stefanopoulos DE; Ryan K; Desai S; Skow D; Kauschke SG; Broermann A; Kuzmich D; Harcken C; Hickey ER; Modis LK
PLoS One; 2014; 9(6):e100883. PubMed ID: 24967665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
